ΠΠΊΡΠΏΡΠ΅ΡΡΠΈΡ ΠΈΠ·ΠΎΡΠΎΡΠΌ ΡΡΡΠ²ΠΈΠ²ΠΈΠ½Π° ΠΏΡΠΈ Π½Π΅ΠΌΠ΅Π»ΠΊΠΎΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΌ ΡΠ°ΠΊΠ΅ Π»Π΅Π³ΠΊΠΎΠ³ΠΎ ΠΈ Π΅Π΅ Π²Π»ΠΈΡΠ½ΠΈΠ΅ Π½Π° ΡΠ²ΠΎΠΉΡΡΠ²Π° Π½Π΅ΠΎΠΏΠ»Π°ΡΡΠΈΡΠ΅ΡΠΊΠΈΡ ΠΊΠ»Π΅ΡΠΎΠΊ
Π ΠΏΠΎΡΠ»Π΅Π΄Π½ΠΈΠ΅ 10 Π»Π΅Ρ Π²ΡΠ΅ Π±ΠΎΠ»ΡΡΠ΅ Π²Π½ΠΈΠΌΠ°Π½ΠΈΡ ΡΠ΄Π΅Π»ΡΠ΅ΡΡΡ ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ ΡΠΎΠ»ΠΈ Π±Π΅Π»ΠΊΠΎΠ² ΡΠ΅ΠΌΠ΅ΠΉΡΡΠ²Π° ΠΈΠ½Π³ΠΈΠ±ΠΈΡΠΎΡΠΎΠ² Π°ΠΏΠΎΠΏΡΠΎΠ·Π°, ΠΈ Π² ΡΠ°ΡΡΠ½ΠΎΡΡΠΈ, ΡΡΡΠ²ΠΈΠ²ΠΈΠ½Ρ Π² ΠΏΡΠΎΡΠ΅ΡΡΠ°Ρ ΠΎΠΏΡΡ ΠΎΠ»Π΅Π²ΠΎΠΉ ΡΡΠ°Π½ΡΡΠΎΡΠΌΠ°ΡΠΈΠΈ ΠΈ ΠΏΡΠΎΠ³ΡΠ΅ΡΡΠΈΠΈ. ΠΡΠ»ΠΈΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΡΡ Π΄Π°Π½Π½ΠΎΠ³ΠΎ Π±Π΅Π»ΠΊΠ° ΡΠ²Π»ΡΠ΅ΡΡΡ Ρ Π°ΡΠ°ΠΊΡΠ΅Ρ Π΅Π³ΠΎ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ. Π‘ΡΡΠ²ΠΈΠ²ΠΈΠ½ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡΡΠ΅ΡΡΡ, Π² ΠΎΡΠ½ΠΎΠ²Π½ΠΎΠΌ, Π²ΠΎ Π²ΡΠ΅ΠΌΡ ΡΠΌΠ±ΡΠΈΠΎΠ³Π΅Π½Π΅Π·Π° ΠΈ ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈ ΠΎΡΡΡΡΡΡΠ²ΡΠ΅Ρ Π²ΠΎ Π²ΡΠ΅Ρ Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΠΊΠ»Π΅ΡΠΊΠ°Ρ Π²Π·ΡΠΎΡΠ»ΠΎΠ³ΠΎ ΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌΠ°… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- Adida Π‘., Berrebi D., Peuchmaur Π., Reyes-Mugica Π., Altieri DC. (1998) Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet 351: 882−3.
- Altieri DC. (2003) Survivin, versatilemodulation of cell division and apoptosis in cancer. Oncogene 22:8581−9.
- Altieri DC. (2003) Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer 3(1): 46−54.
- Altieri DC. (2008) Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8: 61−70.
- Ambrosini G., Adida C., Altieri DC. (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Med. 3: 917−921.
- Andreasen PA., Kjoller L., Christensen L., Duffy MJ. (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer 72: 1−22.
- Avraamides CJ., Garmy-Susini Π., Varner AJ. (2008) Integrins in angiogenesis and lymphangiogenesis. Nature Reviews Cancer 8: 604−617.
- Ballestrem C., Hinz Π., Imhof BA., Wehrle-Haller BJ. (2001) Marching at the front and dragging behind: differential alphaVbeta3-integrin turnover regulates focal adhesion behavior. Cell Biol. 155(7):1319−32
- Banks DP., Plescia J., Altieri DC. (2000) Survivin does not inhibit caspase-3 activity. Blood 96: 4002
- Baran M., Mollers LN., Andersson S., Jonsson IM., Ekwall AK., Bjersing J., Tarkowski A., Bokarewa M. (2009). Survivin is an essential mediator of arthritis interacting with urokinase signalling. J Cell Mol Med. 13(9B):3797−808.
- Bellis SL., Miller JT., Turner CE. (1995) Characterization of tyrosine phosphorylation of paxillin in vitro by focal adhesion kinase. J. Biol. Chem. 270: 17 437−17 441.
- Calalb MB, Polte TR and Hanks SK. (1995) Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol. Cell. Biol. 15: 954−963.
- Caldas H., Jiang Y., Holloway MP., Fangusaro J., Mahotka C., Conway EM., Altura RA. (2005) Survivin splice variants regulate the balance between proliferation and cell death. Oncogene 24(12): 1994−2007).
- CaldasH., Honsey L., Altura R. (2005) Survivin 2a: a novel Survivin splice variant expressed in human malignancies. Molecular Cancer 4:11
- Chakravarti A., Noll E., Black PM., et al. (2002) Quantitatively determined survivin expression levels are of prognostic value in human gliomas. JClinOncol 20:1063−8.
- Chang C., Werb Z., (2001) The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 11(11): 37−43.
- Chantalat L., Skoufias DA., Kleman LP., Jung B., Dideberg O., Margolis RL. (2000) Crystal structure of human survivin reveals a bow tie-shaped dimer with 2 unusual alpha-helical extensions. Mol. Cell 6: 183−189.
- Cheung P., Allis CD., Sassone-Corsi P. (2000) Signaling to chromatin through histone modifications. Cell, 13: 263−271.
- Chiang GC., Sefton BM.(2000) Phosphorylation of a Src kinase at the autophosphorylation site in the absence of Src kinase activity. J. Biol. Chem. 275: 6055−6058.
- Clark SJ., Melki J. (2002) DNA methylation and gene silencing in cancer: Which is the guilty party? Oncogene 21: 5380−5387.
- Cosgrave N., Hill AD., Young LS. (2006) Growth factor-dependent regulation of survivin by c-myc in human breast cancer. J Mol Endocrinol 37: 377−90.
- D’Alessio S, Blasi F. (2009) The urokinase receptor as an entertainer of signal transduction. Front Biosci. 14:4575−87.
- Dasgupta P., Kinkade R., Joshi B., DeCook C., Haura E., Chellappan S. (2006) Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. PNAS 103(16):6332−6337.
- Delacour-Larose M., Thi MN., Dimitrov S., Molla A. (2007) Role of survivin phosphorylation by aurora B in mitosis. Cell Cycle 6(15):1878−85.
- Dohi T., Beltrami E., Wall NR., Plescia J., Altieri DC. (2004a) Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis. J Clin Invest 114: 1117−1127.
- Dohi T., Okada K., Xia F., et al. (2004) An IAP-IAP Complex Inhibits Apoptosis. J Biol Chem 279(33): 34 087−90. a
- Dohi T., Okada K., Xia F., Wilford CE., Samuel T., Welsh K., Marusawa H., Zou H., Armstrong R., Matsuzawa S., Salvesen GS., Reed JC., Altieri DC. (2004) An IAP-IAP complex inhibits apoptosis. J. Biol. Chem. 279: 34 087−34 090.
- Du C., Fang M., Li Y., Li L., Wang X. (2000) Smac a mitochondrial protein that promotes cytochrome C-dependent caspase activation by eliminating IAP inhibition. Cell 102: 33−42.
- Duffy MJ. (2002) Urokinase-type plasminogen activator: a potent marker of metastatic potential in human cancers. Biochem. Soc. Trans. 30: 207−210.
- Endoh T., Tsuji N., Asanuma K., Yagihashi A., Watanabe N. (2005) Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription.
- Fidler, I.J., Kripke, M.L. (1977). Metastasis results from preexisting variant cells within a malignant tumor. Science 197:893−895.
- Fortugno P., Beltrami E., Plescia J., et al. (2003) Regulation of survivin function by Hsp90. Proc Natl Acad Sei USA 100(24): 13 791−6.
- Ghosh JC., Dohi T., Kang BH., Altieri DC. (2008) Hsp60 regulation of tumor cell apoptosis. J Biol Chem 283: 5188−5194.
- Grossman D., Kim PJ., Blanc-Brude O., Brash DE., Tognin S., Marchisio PC., Altieri DC. (2001) Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53. J. Clin. Invest. 108:991−999.
- Grossman D., McNiff JM., Li F., Altieri DC. (1999) Expression and targeting of the apoptosis inhibitor, survivin, in humanmelanoma. J Invest Dermatol 113:1076−81.
- Guha M., Altieri DC. (2009) Survivin as a global target of intrinsic tumor suppression networks. Cell Cycle 8:17, 2708−2710.
- Harfouche R., Hassessian HM., GuoY., et al. (2002) Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells. Microvasc Res 64:135−47.
- Harrell PC., McCawley LJ., Fingleton B., Mclntyre JO., Matrisian LM. (2005) Proliferative effects of apical, but not basal, matrix metalloproteinase-7 activity in polarized MDCK cells. Exp. Cell Res. 303: 308−320.
- Hinnis AR., Luckett JC., Walker RA. (2007) Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients. Br J Cancer 96:639−45.
- Hsu MY., Meier F., Herlyn M. (2002) Melanoma development and progression: a conspiracy between tumor and host. Differentiation 70: 522 536.
- Hu Y., Benedict MA., Ding L., Nunez G. (1999) Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis. EMBO J., 18: 3586−3595.
- Jiang Y., Saavedra HI., Holloway MP., Leone G., Altura RA. (2004) Aberrant regulation of survivin by the RB/E2 °F family of proteins. J Biol Chem 279: 40 511−20.
- Jin Q., Menter GD., Mao L., Hong W., Lee H. (2008) Survivin expression in normal human bronchial epithelial cells: an early and critical step in tumorigenesis induced by tobacco exposure. Carcinogenesis 29(8): 16 141 622.
- John C. Reed JC. (2001) The Survivin saga goes in vivo. J. Clin. Invest. 108: 965−969.
- Jones P., Peak J., Brader S., Eccles S., Katan M. (2005) PLC 1 is essential for early events in integrin signalling required for cell motility. Journal of Cell Science 118: 2695−2706.
- Kang BH., Altieri DC. (2006) Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein. J Biol Chem 281: 24 721−24 727.
- Kappler M., Bache M., Bartel F., et al. (2004) Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53. Cancer Gene Ther 11: 18 693.
- Kawakami H., Tomita M., Matsuda T., Ohta T., Tanaka Y., Fujii M., et al.2005) Transcriptional activation of survivin through the NFkappaB pathway by human T-cell leukemia virus type I tax. Int J Cancer
- Kim PJ., Plescia J., Clevers H., Fearon ER., Altieri DC. (2003) Survivin and molecular pathogenesisof colorectal cancer. Lancet 362: 205−9.
- Kopfstein L., Christofori G. (2006) Metastasis: Cell autonomous versus stroma-contributed mechanisms. Cell. Mol. Life Sci. 63(4):449−68.
- Lee CW., Raskett CM., Prudovsky I., Altieri DC. (2008) Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis. Cancer Research 68: 5273−81.
- Lens SM., Rodriguez JA., Vader G., Span SW., Giaccone G., Medema RH.2006) Uncoupling the central spindle-associated function of the chromosomal passenger complex from its role at centromeres. Mol Biol Cell 17:1897−1909---------------
- Lens SM., Wolthuis RM., Klompmaker R., Kauw J., Agami R., Brummelkamp T., Kops G., Medema RH. (2003) Survivin is required for a112sustained spindle checkpoint arrest in response to lack of tension. EMBO J 22: 2934−2947
- Li F. (2003) Survivin study: what is the next wave? J Cell Physiol. 197: 829.)
- Li F. (2005) Role of survivin and its splice variants in tumorigenesis. British Journal of Cancer 92: 212 — 216.
- Liu T., Brouha B., Grossman D. (2004) Rapid induction ofmitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells. Oncogene 23(l):39−48.
- Loesch M, Chen G. (2008) The p38 MAPK stress pathway as a tumor suppressor or more? Front Biosci. 13:3581−93.
- Mahotka C., Wenzel M., Springer E., Gabbert HE., Gerharz CD. (1999) Survivin- deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Research. 59: 6097−6102.
- Mareel M., Leroy A. (2003) Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev. 83(2):337−76.
- Marioni G., Bertolin A., Giacomelli L., et al. (2006) Expression of the apoptosis inhibitor protein survivin in primary laryngeal carcinoma and cervical lymph node metastasis. Anticancer Res 26:3813−7.
- Marusawa H., Matsuzawa S., Welsh K., Zou H., Armstrong R., Tamm I., Reed J.C. (2003) HBXIP functions as a cofactor of surviving in apoptosis suppression. EMBO J. 22: 2729−2740.
- McNeish IA., Lopes R., Bell SJ., et al. (2005) Survivin interacts with Smac/DIABLO in ovarian carcinoma cells but is redundant in Smac-mediated apoptosis. Exp Cell Res 302(1): 69−82.
- Mehrotra S., Languino LR., Raskett MC, Mercurio AM., Dohi T., Altieri DC. (2010) IAP Regulation of Metastasis. Cancer Cell 17: 53−64.
- Mera S., Magnusson M., Tarkowski A., Bokarewa M. (2008) Extracellular survivin up-regulates adhesion molecules on the surface of leukocytes changing their reactivity pattern. Journal of Leukocyte Biology 83:149−155
- Mesri M., Wall NR., Li J., Kim RW., Altieri DC. (2001) Cancer gene therapy using a survivin mutant adenovirus. J. Clin.Invest. 108:981−990.
- Mita AC., Mita MM., Nawrocki ST., Giles FJ. (2008) Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics Clin Cancer Res 14(16).
- Mizejewski JG. (1999) Role of Integrins in Cancer: Survey of Expression. Patterns Exp. Biol Med. 222: 124−138
- Nakamura K, Yano H, Schaefer E and Sabe H.(2001). Multiple stimuli induce tyrosine phosphorylation of the Crk-binding sites of paxillin. Oncogene. 20: 2626−2635.
- Parise LV., Lee J., Juliano RL. (2000) New aspects of integrin signaling in cancer. Semin. Cancer Biol. 10: 407−414
- Parsons JT., Slack-Davis J., Tilghman R., Roberts WG. (2008) Focal adhesion kinase: targeting adhesion signaling pathways for therapeutic intervention. Clin. Cancer Res. 14: 627—632.
- Romanova YL., Hashimoto S., Chay K., Blagosklonny M., Sabe H., Mushinski J. F. (2004) Journal of Cell Science 117: 3759−3768.
- Salvesen GS., Abrams JM. (2004) Caspase activation stepping on the gas or releasing the brakes? Lessons from humans and flies. Oncogene 23(16): 2774−84.
- Samuel T., Okada K., Hyer M., Welsh K., Zapata JM., Reed JC. (2005) cIAPl Localizes to the nuclear compartment and modulates the cell cycle. Cancer Research 65(1): 210−8 .
- Satoh K., Kaneko K., Hirota M., Masamune A., Satoh A., ShimosegawaT. (2001) Tumor necrosis factor-related apoptosis-inducing ligand and its receptor expression and the pathway of apoptosis in human pancreatic cancer. Pancreas 23: 251−8.
- Schimmer A. (2004) Inhibitor of Apoptosis Proteins: Translating Basic Knowledge into Clinical Practice. Cancer Research 64: 7183−7190.
- Sekimura A., Konishi A., Mizuno K., Kobayashi Y., Sasaki H., Yano M., Fujii Y. (2004). Expression of Smac/DIABLO is a novel prognostic marker in lung cancer. Oncology Reports 11: 797−802.
- Semba S., Trapasso F., Fabbri M., McCorkell KA., Volinia S., Druck T., et al. (2006) Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential. Oncogene 25: 2860−72.
- Span P., Tjan-Heijnen V., Heuvel J., de Kok J., Foekens J., Sweep F. (2006) Do the Survivin (BIRC5) Splice Variants Modulate or Add to the
- Prognostic Value of Total Survivin in Breast Cancer? Clinical Chemistry 52:9 1693−1700.
- Srinivasula S.M., Ashwell J.D. (2008) IAPs: what’s in a name? Mol Cell 30:123−135
- Stauber RH., Wolf Mann., Knauer KS. (2007) Nuclear and Cytoplasmic Survivin: Molecular Mechanism, Prognostic, and Therapeutic Potential. Cancer Research 67(13):5999−6002.
- Stupack DG., Cheresh DA. (2002) Get a ligand, get a life: integrins, signaling and cell survival. J. Cell Sei. 115: 3729−3738
- Suga K., Yamamoto Π’., Yamada Y., Miyatake S., Nakagawa Π’., Tanigawa N. (2005) Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas. Oncol Rep 13(5): 891−897.
- Sun C., Nettesheim D., Liu Z., Olejniczak ET. (2005) Solution structure of human survivin and its binding interface with Smac/Diablo. Biochemistry 44: 11−17.
- Tamm I., Wang Y., Sausville E., Scudiero D.A., Vigna N., Oltersdorf Π’., Reed JC. (1998) IAP-family protein surviving inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases and anticancer drugs. Cancer Research 58:5315—5320
- Tanaka K., Iwamoto S., Gon G., NoharaT., IwamotoM., Tanigawa N. (2000) Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 6:127−34.
- Terada Y. (2001) Role of Chromosomal Passenger Complex in Chromosome Segregation and Cytokinesis. Cell structure and function 26: 653−657.11 l. Tolcher AW., Antonia S., Lewis LD., Mita A., Mahany J., Reddy NJ et al. (2006) ASCO Annual Meeting, 3014.
- Tran J., Rak J., Sheehan C., et al. (1999) Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem Biophys Res Commun 264:781 -8.
- Uren AG., Coulson EJ., Vaux DL. (1998). Conservation of baculovirus inhibitor of apoptosis repeat proteins (BIRPs) in viruses, nematodes, vertebrates and yeasts. Trends Biochem Sei 23:159−62.
- Vaira V., Lee CW., Goel HL., Bosari S., Languino LR., Altieri DC. (2006) Regulation of survivin expression by IGF-l/mTOR signaling. Oncogene 26(19): 2678−84.
- Vegran F., Boidot R., Oudin C., Riedinger JM., Lizard-Nacol S. (2005) Distinct expression of Survivin splice variants in breast carcinomas. Int J Oncol 27(4): 1151−1157.
- Vischioni B., Van der Valk P., Span s., Kruyt F., Rodriguez J., Giaccone G. (2004) Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer. Annals of Oncology 15(11): 1654−1660.
- Vong QP., Cao K., Li HY., Iglesias PA., Zheng Y. (2005) Chromosome alignment and segregation regulated by ubiquitination of survivin. Science 310: 1499−1504.
- Wang T., Qian X., Liu B. (2007) Survivin: Potentional role in diagnosis, prognosis and targeted therapy of gastric cancer. World J of gastroenterol 13(20): 2784−2790.
- Wang RH., Zheng Y., Kim HS., Xu X., Cao L., Luhasen T., et al. (2008) Interplay among BRCA1, SIRT1 and Survivin during BRCA1-associated tumorigenesis. Mol Cell 32: 11−20.
- Yano M., Terada K., Mori M. (2003) AIP is a mitochondrial import mediator that binds to both import receptor Tom20 and preproteins. J Cell Biol 163: 45−56.
- Young JC., Hoogenraad NJ., Hartl FU. (2003) Molecular chaperonesHsp90 and Hsp70 deliver preproteins to the mitochondrial import receptor Tom70. Cell 112: 41−50.
- Zaffaroni N., Pennati M., Daidone MG. (2005) Survivin as a target for new anticancer interventions. J. Cell. Mol. Med. 9(2):360−372.
- Zhang T., Otevrel T., Gao Z., Ehrlich SM., Fields JZ., Boman BM. (2001) Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Research 61: 8664−7.
- Zhang X., Chattopadhyay A., Ji Q., Owen J., Ruest P., Carpenter G., Hanks S. (1999) Focal adhesion kinase promotes phospholipase C-gl activity. Proc. Natl. Acad. Sci. 96: 9021−9026.
- Zhu N., Gu L., Findley HW., Li F., Zhou M. (2004) An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy. Oncogene 23: 7545−7551.